Champion Trader vs Cathie Wood: Who Wins?
A battle between a great trader and a prominent money manager has taken place in recent years. Mark Minervini, 2x US trading champion, has taken shots at billion dollar money manager, Cathie Wood of ARK Invest.
His primary critique appears to be based in a rule that he has observed over time. A stock that has fallen 80% can decline by another 50%. » Read more about: Champion Trader vs Cathie Wood: Who Wins? »
Read More
Billionaires Are Loading Up on This Stock
When you look at search engine market share worldwide, no other comes close to Google (GOOGL)(GOOG). Over the past year, Google held a 92.% global market share, followed by Microsoft Bing with just 3.42%.
In spite of its dominance, Alphabet Inc., Google and YouTube’s parent company,
» Read more about: Billionaires Are Loading Up on This Stock »
Read More
Could Dell Rise 43.4%?
Dell has been around for more than 30 years and, in the past, focused mainly on manufacturing computers and other hardware, but recent acquisitions have broadened its offerings to include software, cloud-based services, data protection and more.
Given the uncertain economic climate, concerns loom over whether Dell can thrive? Will it prosper,
» Read more about: Could Dell Rise 43.4%? »
Read More
1 Stock Down 41% To Buy Now
» Read more about: 1 Stock Down 41% To Buy Now »
Read More
Is Lemonade Stock a Sweet Deal Down 87%
When insurance technology firm Lemonade first debuted on the markets at an official price of $29 before soaring to $66 per share, it was caught up in a frenzy of bullish speculation that subsequently led the stock to rally to $183 per share.
But the excitement wasn’t to last and now the share price sits about 85% lower.
» Read more about: Is Lemonade Stock a Sweet Deal Down 87% »
Read MoreThe Ivy
Is Your Favorite Pharmacy About To Go Belly Up?
Walgreens Boots Alliance stands at a critical juncture in the company’s 170-year history with revenues of $147 billion but a market capitalization of just $7 billion.
A heavily burdened balance sheet has been the prime culprit of the stock’s downfall but, under new CEO Tim Wentworth, management is undertaking an ambitious realignment aimed at stabilizing the core pharmacy business while taking the chop to some of its healthcare investments.
» Read more about: Is Your Favorite Pharmacy About To Go Belly Up? »
Read MoreThe Spotlight
Spotlight: The Next Bloomberg Terminal?
Did you know that every 24 hours, Planet Labs captures imagery of every corner of the Earth? This trove of data is so extensive that it helped track a rogue Chinese spy balloon all the way back to its point of origin.
Similar to a search engine, Planet Labs aims to organize massive amounts of Earth-related data.
» Read more about: Spotlight: The Next Bloomberg Terminal? »
Read MoreThe Daily
3 High-Yield Dividend Stocks to Buy for the Second Half of 2025
If you’ve been investing for a while, chances are you’ve read about maintaining a balanced portfolio. But sometimes it’s hard to know the benefits of diversification unless you’ve experienced them first-hand.
Earlier this year, many growth stocks tanked while value stocks, from Berkshire Hathaway to Coca-Cola, soared as investors flocked to companies that can be counted on no matter what the economy is doing.
» Read more about: 3 High-Yield Dividend Stocks to Buy for the Second Half of 2025 »